Literature DB >> 1979660

MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters.

E V Deverson1, I R Gow, W J Coadwell, J J Monaco, G W Butcher, J C Howard.   

Abstract

The T-cell immune response is directed against antigenic peptide fragments generated in intracellular compartments, the cytosol or the endocytic system. Peptides derived from cytosolic proteins, usually of biosynthetic origin, are presented efficiently to T-cell receptors by major histocompatibility complex (MHC) class I molecules, with which they assemble, probably in the endoplasmic reticulum (ER). In the absence of recognizable N-terminal signal sequences, such cytosolic peptides must be translocated across the ER membrane by a novel mechanism. Genes apparently involved in the normal assembly and transport of class I molecules may themselves be encoded in the MHC. Here we show that one of these, the rat cim gene, maps to a highly polymorphic part of the MHC class II region encoding two novel members of the family of transmembrane transporters related to multidrug resistance. Other members of this family of transporter proteins are known to be capable of transporting proteins and peptides across membranes independently of the classical secretory pathway. Such molecules are credible candidates for peptide pumps that move fragments of antigenic proteins from the cytosol into the ER.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1979660     DOI: 10.1038/348738a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  105 in total

Review 1.  Role of class I molecules of the major histocompatibility complex in cytotoxic T-cell function in health and disease.

Authors:  A J McMichael
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Cytokines activate genes of the endocytotic pathway in insulin-producing RINm5F cells.

Authors:  K L A Souza; M Elsner; P C F Mathias; S Lenzen; M Tiedge
Journal:  Diabetologia       Date:  2004-07-10       Impact factor: 10.122

3.  Evidence for peptide transport across microsomal membranes.

Authors:  B Koppelman; D L Zimmerman; P Walter; F M Brodsky
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

4.  Proteasomes are regulated by interferon gamma: implications for antigen processing.

Authors:  Y Yang; J B Waters; K Früh; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

5.  Developmental failure of chimeric embryos expressing high levels of H-2Dd transplantation antigens.

Authors:  L Jaffe; E J Robertson; E K Bikoff
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

6.  Nomenclature for factors of the HLA system, 1991. The WHO Nomenclature Committee for factors of the HLA system.

Authors: 
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 7.  Dengue fever virus and Japanese encephalitis virus synthetic peptides, with motifs to fit HLA class I haplotypes prevalent in human populations in endemic regions, can be used for application to skin Langerhans cells to prime antiviral CD8+ cytotoxic T cells (CTLs)--a novel approach to the protection of humans.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-09       Impact factor: 2.332

8.  Escherichia coli invasion of brain microvascular endothelial cells in vitro and in vivo: molecular cloning and characterization of invasion gene ibe10.

Authors:  S H Huang; C Wass; Q Fu; N V Prasadarao; M Stins; K S Kim
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Polymorphic peptide transporters in MHC class I monomorphic Syrian hamster.

Authors:  M Lobigs; H S Rothenfluh; R V Blanden; A Müllbacher
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  RFLP analysis of the MHC class III region defines unique haplotypes for the non-obese diabetic, cataract Shionogi and the non-obese non-diabetic mouse strains.

Authors:  T Lund; S Shaikh; E Kendall; R D Campbell; M Hattori; S Makino; A Cooke
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.